In many life sciences organizations, hiring challenges are not primarily caused by candidate shortages. They are caused by internal misalignment between founders, boards, and investors about what success looks like for a given role. This dynamic is often invisible at the outset but becomes increasingly influential as the search progresses.
Each stakeholder group typically brings a different time horizon and risk perspective. Founders are often closest to the science and may prioritize capability depth and cultural fit. Investors tend to focus on capital efficiency and milestone delivery. Boards often sit between these perspectives, attempting to balance governance with strategic direction. When these viewpoints are not explicitly aligned, hiring becomes fragmented.
This fragmentation rarely appears as direct disagreement. Instead, it surfaces as shifting expectations throughout the process. A candidate who is initially attractive may later be reassessed through a different lens as new stakeholders weigh in. What changes is not the candidate, but the implicit criteria being applied.
These dynamics often lead to extended hiring cycles, not because the market lacks talent, but because internal consensus is continuously being renegotiated. In high-growth environments, this can quietly become a structural constraint on execution.
We often see this reflected in how organizations attempt to formalize talent acquisition systems. As discussed in Designing a talent acquisition team that powers growth, structure alone does not resolve alignment issues if decision rights and success criteria remain unclear.
The most challenging aspect of this misalignment is that it is rarely acknowledged directly. Each stakeholder may believe they are aligned with the broader strategy, while still applying different filters in practice. The result is not disagreement, but inconsistency.
Over time, this inconsistency affects more than hiring speed. It influences candidate perception. Senior candidates often recognize when decision-making authority is diffuse or when internal alignment is incomplete. This can introduce hesitation, even when the opportunity itself is strong.
Resolving this issue is not about reducing the number of stakeholders involved. In life sciences organizations, multi-stakeholder input is both necessary and valuable. The real requirement is clarity around how those inputs are synthesized into a final decision framework.
Organizations that solve this early tend to develop a more predictable hiring rhythm. Those that do not often find themselves revisiting similar roles repeatedly, not because they cannot attract talent, but because they cannot converge on selection criteria.
In the end, hiring efficiency is less about external market conditions and more about internal coherence. When founders, boards, and investors operate from a shared definition of success, decisions become faster, clearer, and more durable.
GeneCoda® helps life sciences organizations surface and resolve these alignment gaps early in the hiring process, enabling leadership teams to move from distributed perspective to unified decision-making. Get in touch today.
